Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Aromatherapy with certain essential oils is a safe and effective treatment for hair growth in alopecia areata patients.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Laminaria japonica and Cistanche tubulosa extracts combined may effectively promote hair growth.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.